Alex Azar @SecAzar
To have just one candidate vaccine in Phase 3 trials less than a year after a virus was first reported would be a remarkable accomplishment; to have four candidates at that stage is extraordinary. https://t.co/C0apd4wEoo — PolitiTweet.org